What is less widely known is that fibrinogen in human blood is actually a mixture of variants, each with different functions and properties that could be harnessed to improve existing hemostatic ...

This came after Intas Pharmaceuticals presented the proposal to conduct phase III Clinical trial titled: “A Single Group, Non ...